Final height in central precocious puberty after long term treatment with a slow release GnRH agonist
about
Challenges and controversies in diagnosis and management of gonadotropin dependent precocious puberty: An Indian perspectivePituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat modelsFemale reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complicationsEnd results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty.Management and outcome of central precocious puberty.Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery.Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty.Models for predicting the adult height and age at first menstruation of girls with idiopathic central precocious puberty.Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early puberty.Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 yearsEffects of gonadotropin-releasing hormone agonist therapy on body mass index and height in girls with central precocious puberty.Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in GirlsMale reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group.Predicting the adult height of girls with central precocious puberty.The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty.Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties.Pros and cons of GnRHa treatment for early puberty in girls.Adult height after spontaneous pubertal growth or GnRH analog treatment in girls with early puberty: a meta-analysis.The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early pubertyThe different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty.Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment.Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty.Normal adult height among girls treated for central precocious puberty with gonadotropin-releasing hormone analog therapy.Near final height after GnRH agonist treatment in central precocious puberty.Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience.Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.Gonadotrophin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty.Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.Epidermal growth factor receptor signalling mediates growth hormone-induced growth of chondrocytes from sex hormone-inhibited adolescent rats.Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
P2860
Q28085099-0E88BAE0-D750-4136-A1A1-EF5A91A3CEDEQ28182476-973A13B4-1C2B-4CAB-899B-0971897FBA57Q28383280-A52520C9-CDB8-4244-807D-EE107947378DQ31806004-C1758FD0-F4C7-4888-8FCE-C097074C9D25Q34549875-D95E9CC0-6BE2-404C-933A-DE023308C634Q34711579-4EFFB90E-2153-44F3-AE6F-E5D933CFCB31Q35056370-72194271-CB4A-4ADA-9F75-DD319E2C8217Q35250169-A0561B04-9307-471E-9A52-46F7F3D4C74BQ35261099-9C607CD8-18DC-4A0E-AA86-3A1B7A196F20Q35264882-FF426B23-1B36-4749-9B72-1891BFF6CD09Q35925752-324EE8B0-56C4-41F9-9D1B-C94A26558231Q36080567-FD587E80-FAF8-4D54-8316-6C71F3DC3EB0Q36222944-AF191967-3D78-4EFB-9106-0AE259A51223Q36516478-AFEED515-9E03-4FA0-8531-E522C635752AQ36793078-6EA76E2F-3883-4482-A7A2-4D327154DB24Q38115615-9F8E787A-771A-4E30-969F-8D2ECCD111B7Q38202811-5B4C1F22-5701-40B7-ABE3-B0023156966FQ38863701-7DE11606-AD97-41E1-A5BF-CD24ED772468Q40970685-C91A5503-0B6F-485C-B2FB-44E2795C48DAQ41992890-D93E1851-534F-4CFB-8AAE-101DD35CF582Q43952007-13CFA19A-4020-4477-BA49-380E821562DBQ44599143-CFDC52FC-399D-46D3-85DD-376768DCEED8Q46476454-483B8831-B258-4E51-8A21-1E5CDF157695Q47172921-987AD0C9-E8C6-4ECF-A8B3-9D9B1EB29F36Q47178837-B12FC0D4-B90B-43F3-8F8F-BBFF8A4BE5EDQ47230449-71517EB6-793A-4CF1-BB47-F95BBF3CDF22Q47230463-03A10EF4-E9B0-4697-8548-3B477255D145Q47287444-14E55DC1-48A6-4E37-A276-BFFE9EE74CC3Q49210603-F96458CA-DC48-41B5-B18A-F10E930A1F71Q51625492-27DFE70A-B3EB-46E8-A50D-D60A1A1B9C90Q54585967-5B58C1E5-9ED2-4F70-9EC5-DB7DC6375AB9Q58723433-56178C00-1093-4D71-8F6F-14CAE064045B
P2860
Final height in central precocious puberty after long term treatment with a slow release GnRH agonist
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Final height in central precoc ...... th a slow release GnRH agonist
@ast
Final height in central precoc ...... th a slow release GnRH agonist
@en
Final height in central precoc ...... th a slow release GnRH agonist
@nl
type
label
Final height in central precoc ...... th a slow release GnRH agonist
@ast
Final height in central precoc ...... th a slow release GnRH agonist
@en
Final height in central precoc ...... th a slow release GnRH agonist
@nl
prefLabel
Final height in central precoc ...... th a slow release GnRH agonist
@ast
Final height in central precoc ...... th a slow release GnRH agonist
@en
Final height in central precoc ...... th a slow release GnRH agonist
@nl
P2093
P2860
P356
P1476
Final height in central precoc ...... th a slow release GnRH agonist
@en
P2093
Oostdijk W
Schreuder S
Waelkens J
P2860
P304
P356
10.1136/ADC.75.4.292
P407
P577
1996-10-01T00:00:00Z